All Episodes

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances

Gastroesophageal Cancers | David H Ilson, MD, PhD

Gastroesophageal Cancers | Kohei Shitara, MD

Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Metastatic Bladder Cancer — Rapid Case Review Issue 6

Metastatic Bladder Cancer — Rapid Case Review Issue 5

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma | Robert Z Orlowski, MD, PhD

Multiple Myeloma | Amrita Krishnan, MD

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Maurice Pérol, MD

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | John V Heymach, MD, PhD

For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress

TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2

For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2

Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy (Companion Faculty Lecture)

For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress

Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Localized HR-Positive Breast Cancer | Joyce O'Shaughnessy, MD

Localized HR-Positive Breast Cancer | Harold J Burstein, MD, PhD

Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft

Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Endometrial Cancer — An Interview with Dr Floor J Backes

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay (Companion Faculty Lecture)

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit

Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit

EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD

Urothelial Bladder Cancer | Ashish M Kamat, MD, MBBS

Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit

Prostate Cancer — Fifth Annual National General Medical Oncology Summit

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Colorectal Cancer — Fifth Annual National General Medical Oncology Summit

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

Ovarian Cancer — Fifth Annual National General Medical Oncology Summit

Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit

Multiple Myeloma — Fifth Annual National General Medical Oncology Summit

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck (Companion Faculty Lecture)

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Small Cell Lung Cancer | Jacob Sands, MD

Small Cell Lung Cancer | Christine L Hann, MD, PhD

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

Colorectal Cancer | Arvind Dasari, MD, MS

Colorectal Cancer | Anwaar Saeed, MD

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Jennifer R Brown MD, PhD

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Wojciech Jurczak MD, PhD

Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida (Companion Faculty Lecture)

Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani

Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Oral SERDs for Breast Cancer | Aditya Bardia, MD, MPH

Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer | Scott T Tagawa, MD, MS

Prostate Cancer | Andrew J Armstrong, MD, ScM

Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

Menin Inhibitors in Acute Myeloid Leukemia | Eunice S Wang, MD

Menin Inhibitors in Acute Myeloid Leukemia | Amir Fathi, MD

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Biomarker Assessment and Related Treatment Decision-Making

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Biomarker Assessment and Related Treatment Decision-Making (Companion Faculty Lecture)

Metastatic Bladder Cancer — Rapid Case Review Issue 4

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah (Companion Faculty Lecture)

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting (Companion Faculty Lecture)

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances

Ovarian Cancer | Nicoletta Colombo, MD

Ovarian Cancer | Angeles Alvarez Secord, MD, MHSc

Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Antibody-Drug Conjugates for Breast Cancer | Sara M Tolaney, MD, MPH

Antibody-Drug Conjugates for Breast Cancer | Hope S Rugo, MD

Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy

Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis

Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

Metastatic Bladder Cancer — Rapid Case Review Issue 2

Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih

Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih (Companion Faculty Lecture)

Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 Review

Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore

Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore (Companion Faculty Lecture)

Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Immune Thrombocytopenia — ASH 2025 Review

Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Metastatic Bladder Cancer — Rapid Case Review Issue 1

Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

Relapsed/Refractory Multiple Myeloma — ASH 2025 Review

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Follicular Lymphoma and Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Myelofibrosis and Systemic Mastocytosis — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Chronic Lymphocytic Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2

Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual Meeting

Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Gastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network

CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach (Companion Faculty Lecture)

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

Breast Cancer — Microlearning Activity 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning (Companion Faculty Lecture)

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders (Companion Faculty Lecture)

Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy

ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases

ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders

ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders (Companion Faculty Lecture)

Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis

Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis (Companion Faculty Lecture)

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA

Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA (Companion Faculty Lecture)

Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management

HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment

HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment (Companion Faculty Lecture)

Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors

Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors (Companion Faculty Lecture)

Breast Cancer — An ASCO 2025 Review

Breast Cancer — An ASCO 2025 Review (Faculty Case Presentations)

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic BRCA-Negative Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management

Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management (Companion Faculty Lecture)

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management

Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)

Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy

Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason on Optimizing Patient Care

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients

Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2

Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches

Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches (Companion Faculty Lecture)

Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases

Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Multiple Myeloma | Oncology Q&A for Patients: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma

Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations

Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations (Companion Faculty Lecture)

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma — Optimizing the Selection of First-Line Therapy

Multiple Myeloma | Peter Voorhees, MD

Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances

Endometrial and Cervical Cancer | Susana Banerjee, MBBS, MA, PhD

Ovarian Cancer | Ursula Matulonis, MD

Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management (Companion Faculty Lecture)

Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Chronic Lymphocytic Leukemia — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress

Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress

Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress

Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies (Companion Faculty Lecture)

EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma | Meletios-Athanasios (Thanos) C Dimopoulos, MD

Multiple Myeloma | Robert Z Orlowski, MD, PhD

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Myelofibrosis | John Mascarenhas, MD

Myelofibrosis | Professor Claire Harrison

For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress

Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances

Non-Small Cell Lung Cancer | Joel W Neal, MD, PhD

Non-Small Cell Lung Cancer | Jessica J Lin, MD

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

Non-Hodgkin Lymphoma | Stephen M Ansell, MD, PhD

Non-Hodgkin Lymphoma | Brian T Hill, MD, PhD

Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting

Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress

Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer | Emmanuel S Antonarakis, MD

Prostate Cancer | Professor Karim Fizazi, MD, PhD

Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Breast Cancer | Nancy U Lin, MD

Breast Cancer | Rebecca A Dent, MD, MSc

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD

Chronic Lymphocytic Leukemia | Paolo Ghia, MD, PhD

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress

Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies

Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies

EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

Ovarian Cancer — Proceedings from a Session Held During the 2025 SGO Annual Meeting on Women's Cancer®

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates (Companion Faculty Lecture)

Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 SGO Annual Meeting on Women's Cancer®

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel (Companion Faculty Lecture)

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Oncology Nursing Update: Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig

Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

Colorectal Cancer | Scott Kopetz, MD, PhD

Colorectal Cancer | Jeffrey Meyerhardt, MD, MPH

Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management

Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2

Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy (Companion Faculty Lecture)

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies

Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

EGFR-Mutant Non-Small Cell Lung Cancer | Enriqueta Felip, MD, PhD

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani (Companion Faculty Lecture)

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients

Metastatic Triple-Negative Breast Cancer | Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

Lymphoma | What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

Myelofibrosis | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis

Metastatic Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer

Chronic Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia

Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer

HER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

Colorectal and Gastroesophageal Cancers | Cases from the Community: Integrating New Research Findings into Practice

Hepatobiliary Cancers | Cases from the Community: Integrating New Research Findings into Practice

Gynecologic Cancers | Cases from the Community: Integrating New Research Findings into Practice

Myelofibrosis | Cases from the Community: Integrating New Research Findings into Practice

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

Leukemia and Myelodysplastic Syndromes | Cases from the Community: Integrating New Research Findings into Practice

Lung Cancer | Cases from the Community: Integrating New Research Findings into Practice

Lung Cancer | Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Breast Cancer | Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

Paroxysmal Nocturnal Hemoglobinuria | Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria | Jamile M Shammo, MD

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Multiple Myeloma | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care

Lung Cancer | The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series

Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor (Companion Faculty Lecture)

Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor

Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care

Prostate Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care

Hormone Receptor-Positive Metastatic Breast Cancer | Hope S Rugo, MD

Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Lung Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care

HR-Positive Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care

Lymphoma | Gilles Salles, MD, PhD

Lymphoma | What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

Gastrointestinal Cancers | The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

Metastatic Breast Cancer | Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

Mantle Cell Lymphoma | Michael Wang, MD

Mantle Cell Lymphoma | Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)

HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

Chronic Myeloid Leukemia | Jorge Cortes, MD

Chronic Myeloid Leukemia | Practical Perspectives: Current Management of Chronic Myeloid Leukemia

Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Desmoid Tumors | Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma (Companion Faculty Lecture)

Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma

Metastatic Non-Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

Diffuse Large B-Cell Lymphoma | Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Diffuse Large B-Cell Lymphoma

Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Non-Small Cell Lung Cancer with EGFR Mutations | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)

Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Biliary Tract Cancers | Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Neuroendocrine Tumors | Pamela Kunz, MD

Neuroendocrine Tumors | Simron Singh, MD, MPH

Neuroendocrine Tumors | Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Gastrointestinal Cancers | John Strickler, MD

Gastrointestinal Cancers | Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Gastrointestinal Cancers | Tanios Bekaii-Saab, MD

Non-Small Cell Lung Cancer with an EGFR Mutation | Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Dedifferentiated Liposarcoma | Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma

HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

HR-Positive and Triple-Negative Metastatic Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD

HR-Positive and Triple-Negative Metastatic Breast Cancer | Sara M Tolaney, MD, MPH

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer

Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

Ovarian and Endometrial Cancer | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD

Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD

Non-Small Cell Lung Cancer | Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer

Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer

Multiple Myeloma | Jesús G Berdeja, MD

Multiple Myeloma | Thomas Martin, MD

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Melanoma and Nonmelanoma Skin Cancers | Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review

Renal Cell Carcinoma | Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

Colorectal Cancer | RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

Triple-Negative Breast Cancer | What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

Multiple Myeloma | Breakfast with the Investigators: New Advances in Multiple Myeloma

Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer

Myelofibrosis | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

Prostate Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer

Metastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer

Ovarian and Endometrial Cancer | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer

Antibody-Drug Conjugates | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates

Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers

Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation

Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer'

Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

Breast Cancer | Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

Non-Small Cell Lung Cancer | Justin F Gainor, MD

Non-Small Cell Lung Cancer | Karen Reckamp, MD, MS

Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Gastroesophageal and Colorectal Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Gastroesophageal and Colorectal Cancers

Urothelial Bladder Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer

Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis

Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer

Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer

Prostate Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer

Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers

HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer

Prostate Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer

Acute Myeloid Leukemia | Naval Daver, MD

Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE

Acute Myeloid Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation

Metastatic Triple-Negative Breast Cancer | Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)

Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

Endometrial Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer

Paroxysmal Nocturnal Hemoglobinuria | Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

Prostate Cancer | Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Pancreatic Cancer | Third Annual National General Medical Oncology Summit

Colorectal Cancer | Third Annual National General Medical Oncology Summit

Hepatobiliary Cancers | Third Annual National General Medical Oncology Summit

Gastroesophageal Cancers | Third Annual National General Medical Oncology Summit

Multiple Myeloma | Third Annual National General Medical Oncology Summit

Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit

Targeted Therapy for Non-Small Cell Lung Cancer | Third Annual National General Medical Oncology Summit

Prostate Cancer | Third Annual National General Medical Oncology Summit

Urothelial Bladder Cancer | Third Annual National General Medical Oncology Summit

Renal Cell Carcinoma | Third Annual National General Medical Oncology Summit

Metastatic HER2-Positive and Triple-Negative Breast Cancer | Third Annual National General Medical Oncology Summit

Localized Breast Cancer | Third Annual National General Medical Oncology Summit

Gynecologic Cancers | Third Annual National General Medical Oncology Summit

Hodgkin and Non-Hodgkin Lymphoma | Third Annual National General Medical Oncology Summit

ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology Summit

Ovarian Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty Lecture)

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

Colorectal Cancer | Arvind Dasari, MD, MS

Colorectal Cancer | Thierry André, MD

Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD

Urothelial Bladder Cancer | Shilpa Gupta, MD

Urothelial Bladder Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Prostate Cancer | Andrew J Armstrong, MD, ScM

Prostate Cancer | Maha Hussain, MD, FACP, FASCO

Lymphoma | Andrew M Evens, DO, MBA, MSc

Lymphoma | Sonali M Smith, MD

Lymphoma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Hepatobiliary Cancers | Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD

HER2-Positive and Triple-Negative Breast Cancer | Ian E Krop, MD, PhD

HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

Metastatic Urothelial Bladder Cancer | Virtual Case Library: Metastatic Urothelial Bladder Cancer

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Companion Faculty Lecture)

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer

Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

Gastroesophageal Cancers | Yelena Y Janjigian, MD

Gastroesophageal Cancers | Zev Wainberg, MD, MSc

Gastroesophageal Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers

Chronic Lymphocytic Leukemia | Jeff Sharman, MD

Chronic Lymphocytic Leukemia | Lindsey Roeker, MD

Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Hepatobiliary Cancers | Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers

Prostate Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series

Colorectal Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer

Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer

Gastroesophageal Cancers | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers

Hormone Receptor-Positive Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer

Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO

Hormone Receptor-Positive Breast Cancer | Stephanie L Graff, MD, FACP

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma

Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma

HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer

Chronic Lymphocytic Leukemia | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia

HER2-Negative Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer

Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma

ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer

Gynecologic Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Biliary Tract Cancer | Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers

Biliary Tract Cancer | Milind Javle, MD

Biliary Tract Cancer | Lipika Goyal, MD, MPhil

Lung Cancer | Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

Non-Small Cell Lung Cancer | Aaron Lisberg, MD

Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD

Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Breast Cancer | Implications of Recent Data Sets for the Current and Future Management of Breast Cancer

Gynecologic Cancers | Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series

HER2-Positive and Triple-Negative Breast Cancer | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Multiple Myeloma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Gynecologic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Hepatobiliary and Pancreatic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Urothelial Bladder Cancer and Renal Cell Carcinoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Lymphoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

Chronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Colorectal and Gastroesophageal Cancers | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Non-Small Cell Lung Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Prostate Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

ER-Positive Breast Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

Diffuse Large B-Cell Lymphoma | Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma

Nonmelanoma Skin Cancer | Nikhil I Khushalani, MD

Nonmelanoma Skin Cancer | Anna C Pavlick, DO, MBA

Nonmelanoma Skin Cancer | Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series

Mantle Cell Lymphoma | What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences

Lung Cancer | John V Heymach, MD, PhD

Lung Cancer | Jamie E Chaft, MD

Lung Cancer | Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Colorectal Cancer | Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer

Colorectal Cancer | J Randolph Hecht, MD

Colorectal Cancer | Kristen K Ciombor, MD, MSCI

Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm (Companion Faculty Lecture)

Myelofibrosis | Consensus or Controversy? Documenting and Discussing Clinical Investigators' Practice Patterns in Myelofibrosis

Breast Cancer | Hope S Rugo, MD

Breast Cancer | Tiffany A Traina, MD, FASCO

Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma (Companion Faculty Lecture)

Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer

Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)

Hematologic Oncology | What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

Pancreatic Cancer | Zev Wainberg, MD, MSc

Pancreatic Cancer | Eileen M O'Reilly, MD

Pancreatic Cancer | Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer

Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhD

Non-Hodgkin Lymphoma | Loretta J Nastoupil, MD

Non-Hodgkin Lymphoma | Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Melanoma | Meet The Professor: Optimizing the Management of Melanoma

Lung Cancer | Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

Hepatocellular Carcinoma | The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Prostate Cancer | Neal D Shore, MD

Prostate Cancer | Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma

Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma (Companion Faculty Lecture)

Soft Tissue Sarcoma | Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series

Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences

Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences (Companion Faculty Lecture)

Genitourinary Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

Breast Cancer | Erika Hamilton, MD

Breast Cancer | Aditya Bardia, MD, MPH

Multiple Myeloma | Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management

Multiple Myeloma | Hans Lee, MD

Multiple Myeloma | Saad Zafar Usmani, MD, MBA

Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)

Melanoma and Nonmelanoma Skin Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Melanoma and Nonmelanoma Skin Cancers | Evan J Lipson, MD

Melanoma and Nonmelanoma Skin Cancers | Omid Hamid, MD

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer

Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)

Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Urothelial Bladder Cancer | Petros Grivas, MD, PhD

Urothelial Bladder Cancer | Terence Friedlander, MD

Urothelial Bladder Cancer | Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer

Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on Breast Cancer

Higher-Risk Myelodysplastic Syndromes | David Sallman, MD

Higher-Risk Myelodysplastic Syndromes | Guillermo Garcia-Manero, MD

Higher-Risk Myelodysplastic Syndromes | Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes

Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia (Faculty Lecture)

Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia

Chronic Lymphocytic Leukemia | What I Tell My Patients: New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia

Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria (Faculty Lecture)

Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria

Renal Cell Carcinoma | Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell Carcinoma

Endometrial Cancer | The Implications of New Research Findings for the Management of Endometrial Cancer

Gastroesophageal Cancers | Lunch with the Investigators: Gastroesophageal Cancers

Prostate Cancer | Second Opinion: Investigators Discuss How They and Their Colleagues Apply Available Clinical Research in the Care of Patients with Prostate Cancer

Hodgkin and Non-Hodgkin Lymphoma | Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma

Colorectal and Gastroesophageal Cancers | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Colorectal and Gastroesophageal Cancers

Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

Urothelial Bladder Cancer | Breakfast with the Investigators: Urothelial Bladder Cancer

Hepatobiliary Cancers | Breakfast with the Investigators: Hepatobiliary Cancers

Ovarian Cancer | Breakfast with the Investigators: Ovarian Cancer

Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Breast Cancer

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder Cancer

What I Tell My Patients: Faculty Physicians and Nurses Discuss the Role of Antibody-Drug Conjugates in the Management of HER2-Expressing Cancers Across the Oncology Spectrum

Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Non-Small Cell Lung Cancer

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Diffuse Large B-Cell Lymphoma

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Acute Myeloid Leukemia, Myelodysplastic Syndromes and Myelofibrosis

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Prostate Cancer

Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Ovarian Cancer

Oncology Today with Dr Neil Love — HER2-Positive Metastatic Breast Cancer

Urothelial Bladder Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Hepatobiliary Cancers

Chronic Lymphocytic Leukemia | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia

Prostate Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer

Lung Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Lung Cancer

Biliary Tract Cancers — Richard S Finn, MD

Hepatobiliary Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers

Hepatocellular Carcinoma — Ghassan Abou-Alfa, MD, MBA

Breast Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Breast Cancer

Cervical and Endometrial Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Cervical and Endometrial Cancer

Colorectal Cancer | Pashtoon M Kasi, MD, MS

Colorectal Cancer | Wells A Messersmith, MD

Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Prostate Cancer | Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity

Prostate Cancer | Daniel P Petrylak, MD

Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD

Non-Small Cell Lung Cancer | Heather Wakelee, MD

Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3

Endometrial Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Endometrial Cancer

Myelodysplastic Syndromes | Uma Borate, MD, MS

Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Multiple Myeloma Edition

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer

Urothelial Bladder Cancer | Matthew Milowsky, MD

Renal Cell Carcinoma | Thomas Powles, MBBS, MRCP, MD

Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Ovarian Cancer

Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia Edition

Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part Series

Prostate Cancer | A Oliver Sartor, MD

Prostate Cancer | Tanya B Dorff, MD

Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Gastroesophageal and Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI Webcast

Gastroesophageal Cancers | Zev Wainberg, MD, MSc

Hepatobiliary Cancers | Lipika Goyal, MD, MPhil

Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 2 of a 3-Part Series

Urothelial Bladder Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Urothelial Bladder Cancer

Prostate Cancer | Investigators Discuss Available Research Guiding the Care of Patients with Prostate Cancer

Ovarian Cancer and Tumor Treating Fields | Oncology Today with Dr Neil Love — Role of PARP Inhibition in Ovarian Cancer and Recent Data with Tumor Treating Fields

Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Hepatobiliary Cancers

Lung Cancer | Proceedings from a symposium in partnership with NCOA and SCOS

Gynecologic Cancers | Proceedings from a symposium in partnership with NCOA and SCOS

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a symposium in partnership with NCOA and SCOS

Genitourinary Cancers | Proceedings from a symposium in partnership with NCOA and SCOS

Gastrointestinal Cancers | Proceedings from a symposium in partnership with NCOA and SCOS

Breast Cancer | Proceedings from a symposium in partnership with NCOA and SCOS

Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Renal Cell Carcinoma

Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part Series

Breast Cancer | Ann Partridge, MD, MPH

Breast Cancer | Kathy Miller, MD

Breast Cancer | Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

Gastroesophageal Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal Cancers

Lung Cancer | Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lymphomas | Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting

Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors (Companion Faculty Lecture)

Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors

ER-Positive and Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series

BTK Inhibitors | Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors

Colorectal Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Colorectal Cancer

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer

Hodgkin and Non-Hodgkin Lymphomas | Laurie H Sehn, MD, MPH

Hodgkin and Non-Hodgkin Lymphomas | Christopher R Flowers, MD, MS

Hodgkin and Non-Hodgkin Lymphomas | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas

Thyroid Cancer and Neuroendocrine Tumors | Oncology Today with Dr Neil Love — Thyroid Cancer and Neuroendocrine Tumors

Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation

Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Gynecologic Oncology | Krishnansu S Tewari, MD

Gynecologic Oncology | Kathleen N Moore, MD, MS

Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture)

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting

Multiple Myeloma | Ajay K Nooka, MD, MPH

Multiple Myeloma | Joseph Mikhael, MD, MEd

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer

Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer (Companion Video Lecture)

Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer

Targeted Therapy in Non-Small Cell Lung Cancer | Gregory J Riely, MD, PhD

Targeted Therapy in Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS

Targeted Therapy for Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Chronic Lymphocytic Leukemia | Deborah Stephens, DO

Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD

Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3

Breast Cancer | Joyce O'Shaughnessy, MD

Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD

Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer

Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE

Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD

Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers (Companion Faculty Lecture)

Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers

Multiple Myeloma | Addressing Current Questions and Controversies in the Management of Multiple Myeloma — What Clinicians Want to Know

Hodgkin and Non-Hodgkin Lymphoma | Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma — What Clinicians Want to Know

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)

ER-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer

Chronic Lymphocytic Leukemia | Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia — What Clinicians Want to Know

HER2-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer

Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer (Companion Faculty Lecture)

Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer

Non-Small Cell Lung Cancer | Alexander I Spira, MD, PhD

Non-Small Cell Lung Cancer | Helena Yu, MD

Non‑Small Cell Lung Cancer | Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer

Multiple Myeloma | BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 2

Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma (Companion Faculty Lecture)

Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma

Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer (Companion Faculty Lecture)

Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer

Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2

Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis (Companion Faculty Lecture)

Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis

Acute Myeloid Leukemia | Oncology Today with Dr Neil Love — Novel Agents and Strategies in AML

Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2

Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis

Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma (Companion Faculty Lecture)

Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma

Non-Small Cell Lung Cancer | Stephen V Liu, MD

Non-Small Cell Lung Cancer | John V Heymach, MD, PhD

Non-Small Cell Lung Cancer | Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer

Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 3

Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma (Companion Faculty Lecture)

Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma

Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML

Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML (Companion Faculty Lecture)

Melanoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Ovarian Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Endometrial Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Hepatobiliary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Renal Cell Carcinoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Prostate and Bladder Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes (Companion Faculty Lecture)

Multiple Myeloma| BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 1

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences (Companion Faculty Lecture)

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences

Prostate Cancer | Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1

Chronic Lymphocytic Leukemia | Challenging Cases from Junior Investigators: The Application of Available and Emerging Clinical Research in the Care of Patients with Chronic Lymphocytic Leukemia

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer (Companion Faculty Lecture)

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer

Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis (Companion Faculty Lecture)

Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis

Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors (Companion Faculty Lecture)

Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors

Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 3

Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 1

Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma (Companion Faculty Lecture)

Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma

Diffuse Large B-Cell Lymphoma | Challenging Cases from the Community: Investigators Provide Perspectives on the Optimal Management of Diffuse Large B-Cell Lymphoma

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer (Companion Video Lecture)

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer

Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 2

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer (Companion Faculty Lecture)

Myelodysplastic Syndromes | Exploring Current Considerations and Promising Investigational Approaches for Patients with Myelodysplastic Syndromes

Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 2

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 5

Head and Neck and Thyroid Cancers | Meet The Professor: Optimizing the Management of Head and Neck and Thyroid Cancers

Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer (Companion Faculty Lecture)

Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer

Oncology Today: Management of Endometrial Cancer

Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma (Companion Faculty Lecture)

Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer (Companion Faculty Lecture)

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4

Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 1

Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 2

Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma (Companion Faculty Lecture)

Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma

Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)

Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy

Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 1

Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition

Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition (Companion Faculty Lecture)

Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 5

Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)

Ocular Toxicities | Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy

Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 4

Hematologic Cancers | Data + Perspectives: Investigators Discuss the Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in the Care of Patients with Hematologic Cancers

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3

Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Genitourinary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)

Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting

Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer (Companion Faculty Lecture)

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer

Hepatobiliary Cancers | Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 2

Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting

Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)

Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 4

Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting

Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)

Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 2

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2

Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer

Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer (Companion Faculty Lecture)

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Unresectable Stage III Non-Small Cell Lung Cancer

Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 1

Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting

Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting (Companion faculty lecture)

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Hodgkin and Non-Hodgkin Lymphomas | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hodgkin and Non-Hodgkin Lymphomas

Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers (Companion Faculty Lecture)

Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers

Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 1

Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 1

Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)

Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting

Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 6

Prostate Cancer | Fred Saad, MD

Prostate Cancer | Johann S de Bono, MB ChB, MSc, PhD, FMedSci

Prostate Cancer | PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We're Headed

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1

Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 3

Multiple Myeloma | Breakfast with the Investigators: Multiple Myeloma

Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3

Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer (Companion Faculty Lecture)

Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer

Lung Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma (Companion Video Lecture)

Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma

Urothelial Bladder Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Breast Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Gastrointestinal Cancers| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Cervical and Endometrial Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Ovarian Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Prostate Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Gastroesophageal Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Gastroesophageal Cancers

Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 3

Chronic Lymphocytic Leukemia | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Urothelial Bladder Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 5

Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Hepatobiliary Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hepatobiliary Cancers

Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma (Faculty Presentation)

Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma

Acute Myeloid Leukemia | Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia

Prostate Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting

NSCLC | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 2

Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting

Ovarian Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1

Non-Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Breast Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Prostate Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress